NFA
EDIT icon

Nationwide Fund Advisors’s Editas Medicine EDIT Stock Holding History

Nationwide Fund Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,664
Closed -$448K – 616
2017
Q3 		$448K Sell
18,664
-547
-3% -$10.4K ﹤0.01% 2242
2017
Q2 		$322K Buy
19,211
+15,097
+367% +$272K ﹤0.01% 2409
2017
Q1 		$92K Sell
4,114
-613
-13% -$12.7K ﹤0.01% 2866
2016
Q4 		$77K Hold
4,727
– – ﹤0.01% 2936
2016
Q3 		$64K Hold
4,727
– – ﹤0.01% 3012
2016
Q2 		$115K Buy
+4,727
New +$159K ﹤0.01% 2865
2016
Q1 		– Hold
0
– – – 2904

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Nationwide Fund Advisors's EDIT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Editas Medicine (EDIT) in Q4 2017, closing a stake of 18,664 shares — an estimated $448K sold.

Nationwide Fund Advisors first reported a position in EDIT in Q2 2016 and held it in 6 quarters. The position peaked at $448K in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Editas Medicine position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 18,664 Editas Medicine shares in Q4 2017, an estimated $448K.
  • Nationwide Fund Advisors first reported a position in Editas Medicine in Q2 2016 and held it in 6 quarters.
  • Nationwide Fund Advisors's Editas Medicine position peaked at $448K in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.